7 Leukemia Clinical Trials in Fayetteville, AR (2026)

Q: How do I join a clinical trial in Fayetteville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fayetteville research site will contact you.

Recruiting Leukemia Studies in Fayetteville

NCT07222566Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with chemotherapy) for adults w...

Fayetteville, AR1,410 participantsPfizer

View Study Details

NCT04389632Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

This trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have solid tumors. It will ...

Fayetteville, AR1,006 participantsSeagen, a wholly owned subsidiary of Pfizer

View Study Details

NCT07144280Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

The purpose of this study is to understand if PF-08046054 alone works well compared to standard-of-care docetaxel alone in participants with non-small cell lung cancer (NSCLC) with PD-L1 expression gr...

Fayetteville, AR680 participantsPfizer

View Study Details

NCT07226999Recruiting

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

This study is being done to learn more about a new medicine called PF-08634404 and how well it works when given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fas...

Fayetteville, AR550 participantsPfizer

View Study Details

NCT07061977Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

This phase III trial compares the addition of induction chemotherapy, with carboplatin, paclitaxel and pembrolizumab, to chemotherapy and radiation, with cisplatin and pembrolizumab followed by pembro...

Fayetteville, AR336 participantsNational Cancer Institute (NCI)

View Study Details

NCT07227298Recruiting

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

This study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanced solid tumors. An advanced solid tumor ...

Fayetteville, AR162 participantsPfizer

View Study Details

NCT06998940Recruiting

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

This phase III trial compares the effect of adding panitumumab to standard chemotherapy (with nanoliposomal Irinotecan, leucovorin, and 5-fluorouracil \[5-FU\] or irinotecan, leucovorin, and 5-FU or n...

Fayetteville, AR94 participantsSWOG Cancer Research Network

View Study Details

About Leukemia Clinical Trials in Fayetteville

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 7 leukemia clinical trials recruiting participants in Fayetteville, AR. These studies are seeking a combined 4,238 participants. Research is being sponsored by Pfizer, Seagen, a wholly owned subsidiary of Pfizer, National Cancer Institute (NCI) and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Fayetteville — FAQ

Are there leukemia clinical trials in Fayetteville?

Yes, there are 7 leukemia clinical trials currently recruiting in Fayetteville, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fayetteville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fayetteville research site will contact you about next steps.

Are clinical trials in Fayetteville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fayetteville studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 7 active trials in Fayetteville are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 13, 2026 from ClinicalTrials.gov